These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22782535)

  • 41. [The Choay domain -- the structure responsible for the anticoagulant action of heparins].
    Hemker HC; al Dieri R; Wagenvoord R; Béguin S
    Bull Acad Natl Med; 2003; 187(1):59-66; discussion 66-7. PubMed ID: 14556454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydroxyl-proton hydrogen bonding in the heparin oligosaccharide Arixtra in aqueous solution.
    Beecher CN; Young RP; Langeslay DJ; Mueller LJ; Larive CK
    J Phys Chem B; 2014 Jan; 118(2):482-91. PubMed ID: 24354321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition.
    Duchaussoy P; Jaurand G; Driguez PA; Lederman I; Ceccato ML; Gourvenec F; Strassel JM; Sizun P; Petitou M; Herbert JM
    Carbohydr Res; 1999 Apr; 317(1-4):85-99. PubMed ID: 10466208
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Synthesis of low molecular weight mimetics of heparin].
    Krylov VB; Ustiuzhanina NE; Nifant'ev NE
    Bioorg Khim; 2011; 37(6):745-79. PubMed ID: 22497075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
    Rezaie AR
    Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SR123781A, a synthetic heparin mimetic.
    Herbert JM; Hérault JP; Bernat A; Savi P; Schaeffer P; Driguez PA; Duchaussoy P; Petitou M
    Thromb Haemost; 2001 May; 85(5):852-60. PubMed ID: 11372679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of a Heparinoid Pentasaccharide Containing l-Guluronic Acid Instead of l-Iduronic Acid with Preserved Anticoagulant Activity.
    Herczeg M; Demeter F; Lisztes E; Racskó M; Tóth BI; Timári I; Bereczky Z; Kövér KE; Borbás A
    J Org Chem; 2022 Dec; 87(23):15830-15836. PubMed ID: 36411253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re-visiting the structure of heparin.
    Casu B; Naggi A; Torri G
    Carbohydr Res; 2015 Feb; 403():60-8. PubMed ID: 25088334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides.
    Tatai J; Osztrovszky G; Kajtár-Peredy M; Fügedi P
    Carbohydr Res; 2008 Mar; 343(4):596-606. PubMed ID: 18237719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide.
    Westerduin P; van Boeckel CA; Basten JE; Broekhoven MA; Lucas H; Rood A; van der Heijden H; van Amsterdam RG; van Dinther TG; Meuleman DG
    Bioorg Med Chem; 1994 Nov; 2(11):1267-80. PubMed ID: 7757423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An efficient anticoagulant candidate: Characterization, synthesis and in vivo study of a fondaparinux analogue Rrt1.17.
    Zhang GQ; Jin H; Zhao Y; Guo L; Gao X; Wang X; Tie S; Shen J; Wang PG; Gan H; Cui H; Zhao W
    Eur J Med Chem; 2017 Jan; 126():1039-1055. PubMed ID: 28012344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toward the solid-phase synthesis of heparan sulfate oligosaccharides: evaluation of iduronic acid and idose building blocks.
    Guedes N; Czechura P; Echeverria B; Ruiz A; Michelena O; Martin-Lomas M; Reichardt NC
    J Org Chem; 2013 Jul; 78(14):6911-34. PubMed ID: 23786303
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total synthesis of anticoagulant pentasaccharide fondaparinux.
    Li T; Ye H; Cao X; Wang J; Liu Y; Zhou L; Liu Q; Wang W; Shen J; Zhao W; Wang P
    ChemMedChem; 2014 May; 9(5):1071-80. PubMed ID: 24729477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of Fondaparinux: modular synthesis investigation for heparin synthesis.
    Lin F; Lian G; Zhou Y
    Carbohydr Res; 2013 Apr; 371():32-9. PubMed ID: 23474455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.
    Roy S; El Hadri A; Richard S; Denis F; Holte K; Duffner J; Yu F; Galcheva-Gargova Z; Capila I; Schultes B; Petitou M; Kaundinya GV
    J Med Chem; 2014 Jun; 57(11):4511-20. PubMed ID: 24786387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Efficient Modular One-Pot Synthesis of Heparin-Based Anticoagulant Idraparinux.
    Dey S; Lo HJ; Wong CH
    J Am Chem Soc; 2019 Jul; 141(26):10309-10314. PubMed ID: 31244187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relationship of antithrombotic polysaccharide derivatives.
    Franz G; Alban S
    Int J Biol Macromol; 1995 Dec; 17(6):311-4. PubMed ID: 8789331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of the heparin-based anticoagulant drug fondaparinux.
    Chang CH; Lico LS; Huang TY; Lin SY; Chang CL; Arco SD; Hung SC
    Angew Chem Int Ed Engl; 2014 Sep; 53(37):9876-9. PubMed ID: 25044485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and scalable conversion of L-iduronamides to heparin-related di- and tetrasaccharides.
    Hansen SU; Miller GJ; Baráth M; Broberg KR; Avizienyte E; Helliwell M; Raftery J; Jayson GC; Gardiner JM
    J Org Chem; 2012 Sep; 77(18):7823-43. PubMed ID: 22900939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of sulfonic acid derivatives by oxidative deprotection of thiols using tert-butyl hypochlorite.
    Joyard Y; Papamicaël C; Bohn P; Bischoff L
    Org Lett; 2013 May; 15(9):2294-7. PubMed ID: 23639081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.